Researchers at Huntsman Cancer Institute have found that fewer sessions of higher dose vaginal cuff brachytherapy work just ...

Read on to learn more about your treatment options and outlook if you have platinum-resistant endometrial cancer. Are there treatments for platinum-resistant endometrial cancer? Your doctor may ...

Endometrial cancer (EC) is the most common gynecological malignancy in developed countries, with its incidence steadily rising worldwide due to increasing ...

In a randomized clinical trial, researchers from Huntsman Cancer Institute at the University of Utah (the U) have found that short-course, higher dose vaginal brachytherapy for endometrial cancer had ...

"To date, beyond chemotherapy, there have been limited treatment options for women with advanced, recurrent endometrial cancer in England," said Dr Susana Banerjee, consultant medical oncologist ...

The FDA has granted breakthrough device designation to the ACR-368 OncoSignature assay for use in endometrial cancer.

Treatment plans for atypical uterine bleeding will depend on individual ... such as heart disease, breast cancer, and more. After doctors control initial bleeding, some people may continue with ...

which represent approximately 75% of patients diagnosed with endometrial cancer and who have limited treatment options. Also Read: GSK Highlights New Approvals, Vaccine Momentum At JPMorgan ...

Endometrial cancer is a disease that begins in the lining of the uterus. The primary treatment for endometrial cancer is surgery, including the removal of the uterus, cervix, and upper vagina.